🇺🇸 FDA
Patent

US 7420030

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 7420030 (Aminopeptidase A (APA) targeting peptides for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61K38/00, A61K47/62